Press Release: Elixir : Elixir Medical Announces Excellent, 3-year Clinical and Imaging Results for the CE-Marked Fully Bioresorbable DESolve® Novolimus Eluting Coronary Scaffold System
SUNNYVALE, Calif.--(BUSINESS WIRE)--Excellent, 3-year Clinical & Imaging Results for Elixir's CE-Marked Fully Bioresorbable DESolve® Scaffold System. Golden Tube Visualization, Low MACE and Lumen Gain Sustained Long-Term
Read full article »
Elixir manufactures and markets medical devices and drugs for the treatment of cardiovascular diseases.
Read more